Search filters

List of works by David P Kodack

Antibody-based therapies for the treatment of brain metastases from HER2-positive breast cancer: time to rethink the importance of the BBB?

scientific article published on 22 June 2017

Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy

scientific article

Closing the gap: astrocytes and brain metastasis

scientific article published on 12 August 2016

Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases

scientific article

Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer

Emerging strategies for treating brain metastases from breast cancer

scientific article

FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS

scientific article published on 01 April 2021

PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models

scientific article published on 2 July 2015

Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment

scientific article published on 7 November 2015

The biology of brain metastases-translation to new therapies

scientific article published on 12 April 2011

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation

scientific article published on May 2017

mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1.

scientific article published on 25 October 2013